Annual report pursuant to Section 13 and 15(d)

STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY

v3.19.1
STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balances at beginning at Jul. 23, 2017
Balances at beginning (in shares) at Jul. 23, 2017      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock to Sponsor $ 288 24,712 25,000
Issuance of common stock to Sponsor (in shares) 2,875,000      
Sale of Private Placement Units      
Proceeds from the sale of unit purchase option      
Net income loss (1,176) (1,176)
Balances at ending at Dec. 31, 2017 $ 288 24,712 (1,176) 23,824
Balances at ending (in shares) at Dec. 31, 2017 2,875,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Sale of Units, net of underwriting discounts and offering expenses $ 1,150 112,266,904 112,268,054
Sale of Units, net of underwriting discounts and offering expenses (in shares) 11,500,000      
Sale of Private Placement Units $ 45 4,449,955 4,450,000
Sale of Private Placement Units (in shares) 445,000      
Proceeds from the sale of unit purchase option 100 100
Common stock subject to possible redemption $ (1,104) (112,762,582) (112,763,686)
Common stock subject to possible redemption (in shares) (11,030,442)      
Net income loss 1,021,711 1,021,711
Balances at ending at Dec. 31, 2018 $ 379 $ 3,979,089 $ 1,020,535 $ 5,000,003
Balances at ending (in shares) at Dec. 31, 2018 3,789,558